Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05422911
Title Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors James J. Peters Veterans Affairs Medical Center
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Abiraterone

Apalutamide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.